Safety and Efficacy of Total-Dose Infusion of Low Molecular Weight Iron Dextran for Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease
暂无分享,去创建一个
[1] P. Kalra,et al. Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease. , 2009, Journal of renal care.
[2] S. Bhandari,et al. Improving efficiency and value in health care. Intravenous iron management for anaemia associated with chronic kidney disease: linking treatment to an outpatient clinic, optimizing service provision and patient choice. , 2008, Journal of evaluation in clinical practice.
[3] Ajay K. Singh,et al. Safety of ferumoxytol in patients with anemia and CKD. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[4] R. Ayub,et al. Efficacy and safety of total dose infusion of low molecular weight iron dextran in the treatment of iron deficiency anemia during pregnancy. , 2008, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.
[5] G. D'Haens,et al. A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT®) Randomized Controlled Trial , 2008, The American Journal of Gastroenterology.
[6] G. Wall,et al. Evaluation of total-dose iron sucrose infusions in patients with iron deficiency anemia. , 2008, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[7] A. Berstad,et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. , 2007, Inflammatory bowel diseases.
[8] S. Kathula,et al. Safety and efficacy of total dose infusion of iron dextran in iron deficiency anaemia , 2007, International journal of clinical practice.
[9] I. Koutroubakis,et al. Stimulating erythropoiesis in inflammatory bowel disease associated anemia. , 2007, World journal of gastroenterology.
[10] J. Glaspy,et al. Clinical update: intravenous iron for anaemia , 2007, The Lancet.
[11] T. Menné,et al. Inflammatory bowel disease in relation to contact allergy: A patient-based study , 2007, Scandinavian journal of gastroenterology.
[12] C. Gasche,et al. Systematic review: managing anaemia in Crohn's disease , 2006, Alimentary pharmacology & therapeutics.
[13] J. Hollands,et al. Safety of high-dose iron sucrose infusion in hospitalized patients with chronic kidney disease. , 2006, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[14] E. Kouroumalis,et al. Effectiveness of darbepoetin-alfa in combination with intravenous iron sucrose in patients with inflammatory bowel disease and refractory anaemia: a pilot study , 2006, European journal of gastroenterology & hepatology.
[15] S. Schreiber,et al. Intravenous Iron Sucrose versus Oral Iron Supplementation for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease—A Randomized, Controlled, Open-Label, Multicenter Study , 2005, The American Journal of Gastroenterology.
[16] T. Hausken,et al. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease , 2005, Scandinavian journal of gastroenterology.
[17] I. Cavill,et al. Iron, anaemia, and inflammatory bowel diseases , 2004, Gut.
[18] G. Chertow,et al. On the relative safety of parenteral iron formulations. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[19] J. Ofman,et al. Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. , 2004, The American journal of medicine.
[20] M. H. Schwenk,et al. The safety and efficacy of an accelerated iron sucrose dosing regimen in patients with chronic kidney disease. , 2003, Kidney international. Supplement.
[21] R. Baldassano,et al. Total dose intravenous infusion of iron dextran for iron-deficiency anemia in children with inflammatory bowel disease. , 2002, Journal of pediatric gastroenterology and nutrition.
[22] S. K. Agarwal,et al. TOTAL DOSE INFUSION IRON DEXTRAN THERAPY IN PREDIALYSIS CHRONIC RENAL FAILURE PATIENTS , 2002, Renal failure.
[23] W. Petritsch,et al. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia , 2001, American Journal of Gastroenterology.
[24] F. D'armiento,et al. Allergy and Mucosal Eosinophil Infiltrate in Ulcerative Colitis , 2000, Scandinavian journal of gastroenterology.
[25] R. Pounder,et al. A simple clinical colitis activity index , 1998, Gut.
[26] F Kern,et al. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. , 1976, Gastroenterology.
[27] Ganzoni Am,et al. [Intravenous iron-dextran: therapeutic and experimental possibilities]. , 1970, Schweizerische medizinische Wochenschrift.
[28] G. Bodemar,et al. Treatment of anaemia in inflammatory bowel disease with iron sucrose. , 2004, Scandinavian journal of gastroenterology.
[29] J. Winchester,et al. A randomized trial of three iron dextran infusion methods for anemia in EPO-treated dialysis patients. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[30] J. Lennard-jones,et al. Classification of inflammatory bowel disease. , 1989, Scandinavian journal of gastroenterology. Supplement.